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DNA methylation is an important
mechanism of gene regulation. The most
popular method to measure methylation
is to use BeadChips that contain probes
to index hundreds of thousands of
methylation sites at once. However, these
probes are not equally reliable. In blood
DNA, unreliable probes were less
heritable and less likely to index gene
expression, and associations were less
replicable. This has serious downstream
consequences for reproducible science
and should serve as a caution for all data
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https://doi.org/10.1016/j.patter.2020.100014THE BIGGER PICTURE Although DNA methylation data are used widely by researchers in many fields, the
reliability of these data are surprisingly variable. Our findings remind us that, in an age of increasingly big
data, research is only as robust as its foundations. We hope that our findings will improve the integrity of
DNA methylation studies. We also hope that our findings serve as a cautionary reminder for those gener-
ating and implementing big data of any type: reliability is a fundamental aspect of replicability. Conducting
analysis with reliable data will improve chances of replicable findings, which might lead to more actionable
targets for further research. To the extent that reliable data improve replicability, the knock-on effect will be
more public confidence in research and less effort spent trying to replicate findings that are bound to fail.
Development/Pre-production: Data science output has been
rolled out/validated across multiple domains/problemsSUMMARYDNA methylation plays an important role in both normal human development and risk of disease. The most
utilized method of assessing DNA methylation uses BeadChips, generating an epigenome-wide ‘‘snapshot’’
of >450,000 observations (probemeasurements) per assay. However, the reliability of each of thesemeasure-
ments is not equal, and little consideration is paid to consequences for research. We correlated repeat mea-
surements of the same DNA samples using the Illumina HumanMethylation450K and the InfiniumMethylatio-
nEPIC BeadChips in 350 blood DNA samples. Probes that were reliably measured were more heritable and
showed consistent associations with environmental exposures, gene expression, and greater cross-tissue
concordance. Unreliable probes were less replicable and generated an unknown volume of false negatives.
This serves as a lesson forworkingwithDNAmethylation data, but the lessons are equally applicable towork-
ing with other data: as we advance toward generating increasingly greater volumes of data, failure to docu-
ment reliability risks harming reproducibility.INTRODUCTION of genetic function without changes to DNA sequence. ThisDNA methylation is an epigenetic mechanism that occurs by the
addition of amethyl (CH3) group to DNA, resulting inmodificationThis is an open access article undmechanism plays an important role in human development and
disease, primarily by regulating gene expression.1 Because of
the modifiable nature of epigenetic influence, research intoPatterns 1, 100014, May 8, 2020 ª 2020 The Authors. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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OPEN ACCESS ArticleDNAmethylation has heralded a new era in the elusive search for
the route by which the external world might ‘‘get under the
skin.’’2 By its very nature, this question spans multiple disci-
plines; geneticists,3 biologists,4 computational scientists,5 neu-
roscientists,6 social scientists,7 and philosophers8 have been
drawn to massive new data about the epigenome with an eye to-
ward how it might explain health, disease, and our very nature.
The promise of the epigenetics revolution has been sweeping.
In humans, DNA methylation occurs at specific sites across
the genome (almost exclusively CpG sites, where a cytosine
nucleotide is located next to a guanidine nucleotide), and there
exist hundreds of thousands of such sites. Advances in technol-
ogies for quantifying site-specific DNA methylation have aided
an explosion of research aimed at identifying associations be-
tween numerous environmental exposures, disease processes,
and methylomic variation.9–12 One such measurement technol-
ogy, the Infinium BeadChip produced commercially by Illumina,
has fueledmuch of the research in epigenetic epidemiology. This
platform was developed to simultaneously assay thousands of
DNA methylation targets in the genome. The relative ease of
use, low cost, and modest sample requirements of this technol-
ogy have enabled a new generation of researchers to add DNA
methylation to their research programs, which only a few years
ago would have posed an insurmountable challenge. We are
among this new generation. This article reports our experience,
excitement, and frustration, as a team of multidisciplinary scien-
tists, trying to understand and use these data.
When we began to produce DNA methylation data, we re-
viewed the literature for best-practice information and guidelines
to ensure the highest validity and downstream reproducibility. It
was at this point we realized there was no consensus. We had
generated data using the Infinium Methylation450 (450K) Bead-
Chip, the gold standard for epigenome-wide DNA methylation
data. This provides450,000 measurements per individual sub-
ject. However, we learned that a significant proportion of the
thousands of data points do not yield the equivalent value
when quantified twice from the same DNA sample.13,14 This sit-
uation is compounded by the nature of our work, which involves
repeated measurement of individuals studied longitudinally. This
in itself raises an additional complication: measurement
methods become obsolete and are superseded by new,
improved products. In this case, the 450K BeadChip was
recently replaced by the Infinium MethylationEPIC (EPIC) Bead-
Chip, which containsmost of the content (approximately 93%) of
the 450K BeadChip augmented with probes covering an addi-
tional 400,000 CpG sites. Published research has suggested
that at the array level, DNA methylation values generated using
both iterations of Illumina DNAmethylation BeadChips are highly
correlated, yielding correlations >0.9;15–18 however, the reli-
ability of individual-level probe measurements between the two
arrays varies substantially. Using DNA derived from blood
collected from 145 adults, one study17 observed that reliability
correlations between probes on the 450K and EPIC BeadChip
ranged from 0.34 to 0.95 with a median value of 0.15, and
only 2.6% of the 420,000 probes assayed had reliability corre-
lations above 0.8. Using DNA derived from blood collected from
109 newborns and 86 adolescents, a second study18 observed
similarly low correlations (median r = 0.23, only 10% of probes
with correlations >0.8).2 Patterns 1, 100014, May 8, 2020These aforementioned reports documented patterns of un-
even reliability in the repeated measurement of DNA methyl-
ation.13,14,17,18 However, we were not prepared for the scarcity
of information documenting the consequences of these patterns;
consequences that, if shown to affect inferences made from
DNA methylation data, would have widespread implications for
reproducibility. Most research studies treat the450,000 obser-
vations as ‘‘equals,’’ each as likely as the next to report true bio-
logical differences from a statistical point of view. However, to
uncover consistent, replicable signals of DNA methylation dy-
namics, be it over time, between populations, or between expo-
sures, measurement reliability is crucial. Analysis of probes that
cannot be repeatedly measured with precision has the potential
to yield irreproducible findings borne from spurious associa-
tions, and, just as importantly, may miss discoveries.
Here we share how we went about learning of the cross-disci-
plinary data challenges of high-throughput DNA methylation
data and discuss the implications of these challenges for data
processing, analysis, algorithm generation, and interpretation.
Our goal is to promote communication about careful practices
for working with the new data being generated in this important
field.
We first performed test-retest measurement assessments to
quantify the reliability of DNA methylation data. We assessed
probe reliability between the two types of BeadChips using
data on 350 DNA samples measured twice; once using the
450KBeadChip and again using the EPICBeadChip. The individ-
uals are participants in the E-Risk Study, a birth cohort of 2,232
twins born in 1994–1995 in the United Kingdom. DNA methyl-
ation was measured at age 18 years, when participants contrib-
uted whole blood for DNA analysis. Probe reliability was defined
as the intraclass correlation (ICC) between repeat measures of
individual probe b values measured on the two BeadChips. We
then assessed the impact of differential reliability on numerous
lines of enquiry of interest to many researchers, ourselves
included. First, we tested how reliability influenced the ability
to detect genetic and environmental effects on the epigenome
through (1) analysis of heritability in the E-Risk twin sample and
(2) analysis of methylation quantitative trait loci (mQTLs) identi-
fied in genome-wide association studies (GWAS) of DNAmethyl-
ation. Second, we tested the implications of differential reliability
for association testing by analyzing results of epigenome-wide
association studies of tobacco smoking, one of themost harmful
health risks in the modern world.19 Third, we tested the implica-
tions of differential reliability for epigenetic biomarker develop-
ment by analyzing multi-probe-algorithm-based measurements
that are intended to capture information about aging (i.e.,
‘‘DNA methylation clocks’’). Finally, we tested the implications
of differential reliability in ascribing biological function to DNA
methylation by assessing the impact of reliability on (1) correla-
tions between DNA methylation and gene expression and on
(2) correlations between levels of DNA methylation measured
in blood tissue and brain tissue.
RESULTS
Reliability of CpG Probes Is Low and Highly Variable
We use ‘‘reliability’’ to refer to the reproducibility of methylation
probes’ values. We measured probe values twice from the
ll
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via a single extraction). One set of measures was made using
the 450K BeadChip, the other set using the EPIC BeadChip.
Our analysis was restricted to probes found on both platforms
(438,593 probes).
Probe reliabilities were computed using ICCs calculated for
each of the 438,593 autosomal probes present on both the
EPIC and 450K BeadChips that passed quality control. ICCs
are an oft-used metric to assess reliability in test-retest situa-
tions,20 and many different models exist depending on the way
in which the test-retest data are generated. Here, we calculated
ICCs based on amean-rating (k = 2), absolute-agreement, 2-way
random-effectsmodel.We chose thismodel using the guidelines
outlined by Koo and Li,20 where mean-rating (k = 2) relates to the
number of repeated measures (i.e., BeadChips per sample); ab-
solute agreement requires that not only do the values across
BeadChips correlate but that values are in agreement; and 2-
way random effects relates to the generalizability of the ICCs
to any subsequent similarly characterized rater (where rater =
BeadChip probe).
ICCs between probes ranged from 0.28 to 1.00 (Supple-
mental Information, Section 1.1; Figure S1; Data S1). Probe reli-
abilities were skewed toward zero, with amean of 0.21 (median =
0.09). This is low reliability considering that, in the context of es-
tablishing reliable measurement, ICCs below 0.4 are considered
‘‘poor,’’ those between 0.4 and 0.6 are considered ‘‘fair,’’ be-
tween 0.6 and 0.75 ‘‘good,’’ and above 0.75 ‘‘excellent.’’21
The reliabilities that we observed in our data were highly corre-
lated with the reliabilities observed by Logue et al.,17 who also
compared probes across 450K and EPIC BeadChips (r = 0.86,
p < 0.01, Supplemental Information, Section 1.1; Figure S2).
This suggests that the low reliabilities that we observed across
the arrays are reproducible in other datasets. Importantly, the
low reliabilities that we observed were unlikely to be solely due
to differences between 450K and EPIC BeadChip probes. First,
previous studies have documented similar low reliabilities in
450K-450K probe comparisons13,14 and EPIC-EPIC probe com-
parisons.17 Second, we conducted EPIC-EPIC array compari-
sons for a subset of Dunedin Study samples (n = 28) (for compar-
ison purposes, we restricted analysis to the 440,000 probes
overlappingwith the 450K array as described throughout this pa-
per). Several noteworthy details emerged. (1) The median reli-
ability in our EPIC-EPIC comparison was 0.26. This is higher
than the median reliability (0.09) observed in our 450K-EPIC
comparisons, but still falls squarely in what is considered to be
‘‘poor’’ reliability.21 (2) It is not clear what accounts for the higher
EPIC-EPIC reliability; it could be due to consistency of the plat-
form or it could be due the fact that, unlike probes for the 450K-
EPIC comparisons, probes for the EPIC-EPIC were assayed at
the same time, using the same reagents, equipment, and so
forth. (3) The correlations between the EPIC-EPIC reliabilities
estimated by us in the Dunedin Study with the 450K-EPIC reli-
abilities (estimated by us in the E-Risk Study) was 0.77 (Fig-
ure S3). (4) When performing the analyses set forth in this manu-
script using EPIC-EPIC ICCs rather than 450K-EPIC ICCs, we
arrive at the same conclusions: we found that, like between-
array reliability, within-array reliability is low, skewed toward
zero, and has detrimental effects on research findings, and
that differences in 450K and EPIC BeadChip probes are unlikelyto be the sole cause of between-array unreliability (Supplemental
Information, Section 1.1).
As a sanity check, we also sought to replicate previously
observed associations between reliability and (1) the mean and
standard deviation (SD) of methylation levels (b values)13,14,17
(Supplemental Information, Section 1.2) and (2) the genomic
annotation (location) of probes13,18 (Supplemental Information,
Section 1.3). We observed the same associations as previously
reported. Taken together, this suggests BeadChip-wide differ-
ential reliabilities are reproducible and systematic in pattern.
Previousmethodological studies have drawn attention to three
factors that might compromise the quality of methylation Bead-
Chip data: probe invariance,22–24 potential probe hybridization
problems,25 and skewness.26 We tested whether these features
are sufficient to capture unreliability. They are not. Probe unreli-
ability exists in probes that are variable or do not have potential
probe hybridization problems, and probe reliabilities calculated
on b values resemble the reliabilities of M values, a method for
transforming skewed probe distributions26 (Supplemental Infor-
mation, Section 1.4).
In summary, we replicated previous reports of low reliability
across probes common to the 450K and EPIC BeadChips,
demonstrating that, paradoxically, poor reliability is reproduc-
ible. Moreover, factors commonly thought to account for unreli-
ability (such as invariance) do not provide a satisfactory account
of its ubiquity.
Evaluating the Consequences of Unreliable Probe
Measurements
Our data suggest that the majority of probes we tested have low
test-retest reliability. We now examine the practical implications
of this observation for epigenetic research by applying our 450K-
EPIC reliabilities to the results of previously published epigenetic
studies. In all cases, these previously published studies were
based on data derived using 450K BeadChips because (1) the
EPIC BeadChip is relatively new, and most published research
is based on the 450K BeadChip, (2) the probes common to the
EPIC and 450K BeadChips reflect almost all (93%16) of the
probes unchanged from the 450K BeadChip, and (3) earlier
450K-450K comparisons showed patterns of reliabilities similar
to those of the 450K-EPIC comparison.13,14
Estimates of Genetic and Environmental Effects on DNA
Methylation Are Affected by Unreliable Measurement
Genetic and environmental effects on a phenotype can be esti-
mated by comparing the relative phenotypic differences be-
tween monozygotic (MZ) and dizygotic (DZ) twins. The assump-
tions behind this model are that additive genetic factors are
perfectly correlated betweenMZ twins (i.e., genetic correlation =
1) but are only 50% correlated between DZ twins (i.e., genetic
correlation = 0.5) and that shared non-heritable influences are
equally similar between MZ and DZ twin pairs. We previously re-
ported the probe-specific genetic and environmental architec-
ture of DNA methylation.24 Using our twin design, we decom-
posed variation in each probe into three variance components:
additive genetic effects (labeled ‘‘A’’), shared environmental ef-
fects (‘‘C’’; environmental effects that each twin in a twin pair
share, making twins more similar to each other), and non-shared
(or unique) environmental effects (‘‘E’’; environmental effects that
are specific to each twin within a pair, making twins less similar toPatterns 1, 100014, May 8, 2020 3
Figure 1. Density Heatmap of Probe Reliability Plotted against Esti-
mates of Genetic and Environmental Effects on DNA Methylation
(A) Additive genetic effects (denoted as ‘‘A’’), (B) shared environmental effects
(denoted as ‘‘C’’), and (C) non-shared (or unique) environmental effects (de-
noted as ‘‘E’’). The variance component is plotted on the x axis and the reli-
ability is plotted on the y axis. Probes with the highest reliability have the
highest value of A and lowest value of E. Density is depicted on a spectral scale
from low (dark blue) to high (red).
ll
OPEN ACCESS Article
4 Patterns 1, 100014, May 8, 2020each other). Figure 1 shows the association between probe reli-
ability and estimates of A (Figure 1A), C (Figure 1B), and E (Fig-
ure 1C). Reliability was significantly correlated with higher herita-
bility (r = 0.70, p < 0.01, Figure 1A). In contrast, low-reliability
probes tended to be suffused with more non-shared environ-
mental variance (r = 0.58, p = 1.00, Figure 1C). Given that the
non-shared environmental variance component in biometric
models also includes measurement error, these probes are
possibly less likely to reflect true environmental effects than
they are to reflect unreliable measurement. (The correlation be-
tween reliability and estimates of shared environmental variance
[C] was low, r = 0.07, possibly reflecting the fact that the clas-
sical twin design has limited power to identify precise estimates
of shared environmental influence.27)
We further examined how unreliability affects discovery
research about the genetic etiology of DNAmethylation. A recent
GWAS of DNA methylation identified 55,000 methylation
mQTLs, DNA sequence variants that are associated with differ-
ential DNA methylation.28 Figure 2 shows that the reliability of
probes indexed by mQTLs in our data (N = 50,900) is higher
than the reliability of probes that are not (N = 387,693).
In summary, given that a significant proportion of probes are
suffused with unreliability (as indicated by poor test-retest reli-
ability and as further indexed by high E-components in biometric
models), the ability to detect associations between DNA methyl-
ation levels and genetic influences will be compromised.
Probe Reliability Affects Association Testing
We hypothesized that reliability is related to the likelihood that
associations between environmental exposures and specific
probes would replicate across independent studies. To test
this, we focused on one of the most robust findings in epigenetic
epidemiology: the effect of tobacco smoking on DNA methyl-
ation. We identified 22 studies that reported an epigenome-
wide analysis of current versus never smoking using the 450K
BeadChip platform12,29–34 (Table S4). For each study, we ob-
tained lists of probe IDs and direction of effect for probes that
were significantly associated with current smoking (as deter-
mined by the study authors; total number of probes = 3,724;
number of probes per study = 84–2,441). We then determined
the extent to which individual probes replicated across the 22
studies by summing the number of times each probe was listed
with consistent direction of effect (i.e., consistent cross-study in-
creases or decreases in methylation in response to smoking).
The number of individual replications across studies was associ-
ated with reliability (r = 0.52, p < 0.001, Figure 3). The mean num-
ber of replications for low-reliability probes (here defined as reli-
ability <0.4) was 6.84 (median = 1, SD = 6.78, n = 1,630 probes),
whereas the mean for high-reliability probes (reliability >0.75)
was 13.1 (median = 15, SD = 5.11, n = 391 probes).
In summary, the likelihood of replicating associations between
exposures and DNA methylation probes is significantly greater
when studying reliable probes. Unreliable probes are likely to
generate false positives and to mask true associations and are
less likely to be reproducible.
Publicly Available DNA Methylation Aging Algorithms
Contain Unreliable Measurements
There is enormous interest in developing and applying algo-
rithms that use DNA methylation to index biological aging.35 A
critical component of the success of these ‘‘DNA methylation
Figure 2. The Distribution of Reliabilities of
Probes Identified in a Large-Scale mQTL
Analysis Compared with Non-mQTL Probes
Distributions are depicted as box-and-whisker plots
of the reliability coefficients of the probes identified
as having mQTLs (‘‘mQTL’’) and the remainder not
included in the mQTL list (‘‘no mQTL’’). Boxes
correspond to interquartile range (IQR), and whis-
kers extend to 1.5 3 IQR. Observations beyond the
whiskers (outliers) are represented by individual
points. As a reference, the distribution (pink bars)
and median (vertical dashed line) of all 440,000
probe reliabilities in the E-Risk dataset is shown
above the box-and-whisker plots. The text box
shows the results of gene set enrichment analysis
(GSEA; NES, normalized enrichment score; N,
number of probes); probes associated with mQTLs
are enriched for reliable probes, suggesting that
reliable probe measurement is important for un-
covering genetic effects on methylation.
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measured so that they might be applied to any external dataset.
We tested the hypothesis that these algorithms are more likely to
capture reliable probes than unreliable probes. Figure 4 shows
the distribution of probe reliabilities for three established DNA
methylation aging-associated clocks: (1) the ‘‘Hannum clock,’’36
(number of probes = 63), (2) the ‘‘Horvath clock’’37 (number of
probes = 334), and (3) the ‘‘Levine clock’’38 (number of probes =
512; the number of probes reflects those available in our data).
Each aging algorithm had median probe reliabilities higher than
that of the background distribution. However, the distribution
for all three algorithms was not solely composed of reliable
probes; each algorithm contained many probes whose b values
were unreliable.
In summary, externally validated DNA methylation algorithms
are generally composed of reliable probes. However, their per-
formance could be improved by utilizing more reliable DNA
methylation measurements. This perhaps emphasizes the point
that algorithms of this type necessitate careful, extensive
external validation; we hypothesize that algorithms over-repre-
sented by unreliable probes will, by their very nature, fail to
perform well under varied testing situations.
Reliability Influences the Association between DNA
Methylation and Gene Expression
A goal of epigenetic discovery is to assign biological meaning to
the observed patterns of DNA methylation (e.g., Schubeler2 and
Teschendorff and Relton39). To this end, we tested the hypothe-
sis that DNAmethylation probes with higher reliability were more
likely to index variation in gene expression, the process by which
the information encoded in a gene is used to direct the assembly
of a protein molecule. We used two approaches.
First, we used the results of global DNA methylation-gene
expression correlation patterns described by Kennedy et al.,40
wherein 36,485 and 114,536 unique DNA methylation probes
were associated with gene expression across two cohorts
(GTP and MESA, respectively; p < 1 3 105). Figure 5A shows
that these significantly correlated methylation probes were
more likely to be reliable (median reliability in GTP = 0.21, propor-
tion of these probes with reliability >0.75 = 11.2%; median reli-ability in MESA = 0.20, proportion of these probes with reliability
>0.75 = 10.1%; gene set enrichment analysis [GSEA] enrichment
p < 1 3 104 in each) than methylation probes that were not
discovered to be related to gene expression. Furthermore,
probes that were significantly correlated with gene expression
in both datasets had higher reliabilities than those identified in
only one dataset (median reliability = 0.36 versus 0.17, propor-
tion of probes with reliability >0.75 = 14.7% versus 9.4% for
both datasets versus one dataset, respectively; GSEA enrich-
ment p < 13 104). This suggests that reliability of DNA methyl-
ation probes influences the ability to detect correlates of biolog-
ical function in a reproducible manner.
Second, using gene expression data available in the Dunedin
Study, we calculated the correlation between gene expression
probeset values with DNA methylation b values for every CpG
probe localized to the transcription start site (TSS) of that
gene. We restricted analysis to probes within the TSS, as these
are hypothesized to have direct effects upon expression of the
localized gene. As shown in Figure 5B, DNA methylation probes
that significantly correlated with expression probesets (a = 1 3
107, n = 278) had significantly higher reliabilities than DNA
methylation probes that did not (n = 23,261; median reliability
of correlated probes = 0.64, proportion of these probes with reli-
ability >0.75 = 36.0%; median reliability of non-correlated
probes = 0.04, proportion of these probes with reliability
>0.75 = 3.4%; Figure 5C).
In summary, DNA methylation probes were more likely to
correlate with transcriptional variation if they were reliably
measured. Reliable probes are more likely to index reproducible
biological correlates, whereas unreliable probes may mislead
about biological function.
Reliability Influences the Concordance of Blood and
Brain Methylation Levels
Most epidemiological investigations into exposure-related dif-
ferential DNA methylation are undertaken using DNA derived
from whole blood. This is an expedient choice due to the relative
ease of collecting blood in population-based studies. However,
many exposures in which epidemiologists are interested are hy-
pothesized to have their effects (or consequences) in otherPatterns 1, 100014, May 8, 2020 5
Figure 3. Probes Consistently Associated with Smoking across
Studies Have Higher Reliabilities Than Probes that Are Not
We identified 22 epigenome-wide association studies of smoking and DNA
methylation. For ease of visualization, probes have been binned into three
groups representing 1–7 replications (pink), 8–14 replications (green), and 15–
22 replications (blue). The values above the x axis represent the number of
probes per group. In the 1–7 replication bin, the highest density of probes was
at the low-reliability end of the distribution, and the median reliability (as de-
picted by the median line of the box plot within the violin) was the lowest of the
three groups. Boxes correspond to IQR and whiskers extend to 1.5 3 IQR.
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eral blood is a problematic surrogate tissue. Previously, we eval-
uated the similarity of methylation levels between bloodDNA and
DNA from four brain regions (prefrontal cortex, entorhinal cortex,
superior temporal gyrus, and cerebellum) using the 450K Bead-
Chip, and showed that only a small proportion of probes
measured in blood correlate with methylation levels in the
brain.41
We hypothesized that these small numbers of probes that reg-
ister similar levels of DNA methylation in blood and brain tissue
would be over-represented by high-reliability probes. To test
this, we cross-referenced the correlations between DNAmethyl-
ation levels in blood and each of four brain regions (‘‘blood-brain
concordance’’) with our 450K-EPIC probe reliabilities. Blood-
brain concordance was related to reliability (rho = 0.22–0.38,
p < 0.01 across the four brain regions). Figure 6 shows the distri-
bution of reliability across low- (<0.4), mid- (0.4–0.75), and high-
concordance (>0.75) probes in four brain regions. Median reli-
abilities for probes with low blood-brain concordance were
0.08 regardless of brain region, while median reliabilities for
probes with high blood-brain concordance were 0.90 across
the four brain regions. Moreover, probes that showed high
blood-brain concordance in all four brain tissues were the
most reliable (median reliability = 0.92, number of probes =6 Patterns 1, 100014, May 8, 20206,774, proportion of these probes with reliability >0.75 =
78.7%) while probes that had low blood-brain concordance in
each of the four brain tissues were the least reliable (median reli-
ability = 0.08, number of probes = 397,091, proportion of these
probes with reliability >0.75 = 3.1%).
In summary, reliable probes aremore likely to exhibit cross-tis-
sue concordance in DNA methylation. Unreliable probes may be
less likely to prove useful in developing blood-based biomarkers
of brain dysregulation.
DISCUSSION
The reliability of probe-level DNA methylation measurement is
highly variable across the 440,000 sites indexed on the 450K
and EPIC BeadChips. This differential reliability has detrimental
downstream implications: it undermines published research
and masks potential new discoveries.
First, we demonstrated that detection of both environmental
and genetic effects on DNA methylation is related to differential
probe reliability. The extent to which DNA methylation responds
to environmental influences is under intense investigation and is
thought to be one route via which environmental exposures ‘‘get
under the skin.’’2 There is also much interest in the relationship
between DNA sequence variation and DNA methylation.23,24
Here, we showed that the most reliable probes tend to be under
significant genetic influence, whereas the least reliable probes
are suffused with non-shared environmental variation (which
also includes variation arising due to measurement error). These
findings suggest that for a proportion of sites that indicate high
sensitivity to environmental input, identification of true signal
might be hindered by the relatively higher probability of impre-
cise measurement and that insights into the genetic basis of
methylation may be missed due to the poor reliability of DNA
methylation.
Second, we demonstrated the implications of differential reli-
ability for epigenome-wide association testing. To achieve this
we focused on tobacco smoking, one of themost replicable find-
ings in epigenetic epidemiology. Here we showed that the likeli-
hood of replication across studies increases with probe reli-
ability. We also showed how unreliable probes may slow
biomarker discovery. Arguably, ‘‘DNA methylation clocks’’
have been one of the major success stories of epigenetic epide-
miology.36–38 We found that these clocks are enriched for reli-
able probes but that the algorithms also contain noisy measure-
ments, and it is possible that applying machine learning to
uniformly reliable data will improve precision in this and
other areas.
Third, we demonstrated the implications of differential reli-
ability for integrating DNA methylation data with sequence and
transcriptomic data. Here we showed that probe reliability is
necessary to accurately estimate genetic contributions to DNA
methylation, to identify gene expression correlates, and to
detect correlated DNA methylation signatures across tissues. If
the goal is robust and replicable biological inference from site-
specific DNA methylation, it is necessary to restrict analysis to
those probes that can be reliably measured.
There are some caveats to this study. First, these findings are
restricted to DNA derived from blood. However, findings
described here will be of use to the majority of researchers in
Figure 4. Reliabilities of Probes Included in
Established, Publicly Available DNA Methyl-
ation Algorithms (‘‘Clocks’’)
Distributions are depicted as box-and-whisker plots
of the reliability coefficients of the probe constitu-
ents of the Hannum et al.36 aging clock (63 probes),
Horvath37 DNAmAge clock (334 probes), and Levine
et al.38 biological aging clock (512 probes). Boxes
correspond to IQR and whiskers extend to 1.5 3
IQR. Observations beyond the whiskers (outliers)
are represented by individual points. As a reference,
the distribution (pink bars) and median (vertical
dashed line) of all 440,000 probe reliabilities in the
E-Risk dataset is shown above the box-and-
whisker plots. The aging clocks are enriched for
reliable probes (values to the right of the figure; NES,
normalized enrichment score; N, number of
probes). Median reliabilities of probes included in
aging clocks are higher than those of the general
distribution; however, each algorithm contained
many unreliable probes.
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application of epigenetic findings, since blood is the most com-
mon substrate from which DNA is derived and biomarkers are
developed. Second, our study comprises young adults; it is
possible that age-related change in DNA methylation at certain
sites in the genome influences the pattern of reliability. That
said, the pattern of reliability coefficients observed in our study
is consistent with that seen in newborns,18 14-year-olds,18 and
30-year-olds.17 Third, findings are restricted to the 440,000
probes common to both the 450K and EPIC BeadChips. Howev-the Dunedin Study dataset. Probes that were significantly correlated with gene ex
(C) Distribution of reliabilities of these significantly correlated DNA methylation pro
normalized enrichment score; N, number of probes); DNA methylation probes
reliable probes.er, Logue et al.17 reported similar reliability distributions for EPIC-
EPIC comparisons in 11 individuals and we found better, but
overall poor reliability for EPIC-EPIC comparisons in our data
as well. Moreover, for the probes overlapping the two arrays,
the EPIC-EPIC reliabilities were highly correlated with the
450K-EPIC reliabilities. The reason we emphasize between-
array probe comparisons is that the goal of many researchers’
work is to both make discoveries and replicate discoveries
made by others. Given rapid advances in technologies and the
proliferation of available data, it is increasingly the case thatFigure 5. Reliabilities of Probes Significantly
Correlated with Gene Expression Have
Higher Reliabilities Than Non-correlated
Probes
(A) Distributions of the reliability coefficients of the
probes identified as correlated with gene expres-
sion by Kennedy et al.40 in the GTP and MESA co-
horts (N probes = 36,485 and 114,536, respec-
tively). Probes that are correlated with gene
expression in both cohorts are shown in the bottom-
most box-and-whisker plot. Boxes correspond to
IQR and whiskers extend to 1.5 3 IQR. As a refer-
ence, the distribution (pink bars) and median (verti-
cal dashed line) of all 440,000 probe reliabilities in
the E-Risk dataset is shown above the box-and-
whisker plots. The text box shows the results of
GSEA for the GTP cohort, MESA cohort, and the
intersection of both cohorts (NES, normalized
enrichment score; N, number of probes). Each co-
hort’s set of significantly correlated DNA methyl-
ation probe-gene expression pairs is enriched for
reliable probes; pairs that are significantly corre-
lated in both datasets are further enriched.
(B) TSS-localized DNA methylation probe-gene
expression probeset correlation (x axis) plotted
against DNA methylation probe reliability (y axis) in
pression are shown in pink (n = 278) and those not correlated are shown in blue.
bes as a box-and-whisker plot. The text box shows the results of GSEA (NES,
that were significantly correlated with expression probesets are enriched for
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Figure 6. Violin Plots of the Distribution of
Reliability in Probes with Low (<0.4, Pink),
Medium (0.4–0.75, Green), and High (>0.75,
Blue) Blood-Brain Correlation in DNA
Methylation
Distributions are shown across four brain regions:
prefrontal cortex (A), entorhinal cortex (B), superior
temporal gyrus (C), and cerebellum (D). Number of
probes per group is listed above the x axis. Box-
and-whisker plots of the distribution are plotted
within violin plots. Values below each violin corre-
spond to the number of probes in that group.
Probes with high blood-brain concordance are
concentrated at the high-reliability end of the dis-
tribution. Boxes correspond to IQR and whiskers
extend to 1.5 3 IQR.
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different arrays; indeed, although the 450K chip is no longer
available, the vast bulk of DNA methylation research to date
has used this array. As such, an important challenge for data sci-
entists is how to integrate data from different arrays, whether this
is in the service of evaluating targets for further scientific interro-
gation or in meta-analysis (e.g., one needs to knowwhether pub-
lished results generated by 450K data are generalizable to new
EPIC data and, ultimately, whether EPIC data will be generaliz-
able to new technologies in future). In this case, between-array
reliability is the relevant metric.
Taken together, at the very least unreliable probes are uninfor-
mative. At worst, they hinder scientific progress. In the GWAS
world, much has been done to improve replicability of research,
from increasing sample sizes to standardizing data pipelines
(e.g., Visscher et al.42). In the epigenetic world, researchers
have adopted many similar considerations (e.g., Lehne et al.43
and Yan et al.44), but unreliability in the quantitative measure-
ment of DNA methylation is a unique challenge. We list possible
responses below.
First, to approximate reliable measurements, it is possible to
filter data based on intrinsic properties of probes, such as invari-
ance or hybridization properties. However, restricting analysis to
variant probes or to probes without sequence-related perfor-
mance issues is not sufficient to guarantee reliability; we found
that these probes were not uniformly reliable (Supplemental In-
formation, Section S1.4). Furthermore, restricting analysis to
only variant probes conveys no enhancement of power to detect
associations between reliability and (1) estimates of genetic and
environmental influences on DNAmethylation, (2) mQTL probes,
and (3) concordance in DNA methylation levels between blood
and brain tissue (Supplemental Information, Section S2). Sec-
ond, it is possible to return to the practice, once routine, of using8 Patterns 1, 100014, May 8, 2020alternative technologies such as pyrose-
quencing to perform post-analysis valida-
tion of positive DNA methylation findings.
This approach comes with two caveats,
one of which is that it can only detect false
positives; false negatives would remain
undetected. A second caveat is that as
science is shifting toward a culture of
open-access and publicly available data,more and more researchers are becoming endpoint data users
and as such are not involved in experimental data production.
In this scenario, the task of experimental validation of individual
findings, potentially in the thousands, is resource heavy, logisti-
cally impractical, and financially prohibitive. A third response is
to generate pre-analysis reliability metrics, as we did in this
report. Indeed, for publicly available data, this is currently the
only feasible method of providing individual probe reliability met-
rics to end-users. To aid standardization, we have made avail-
able our reliability metrics for all measured probes (Data S1).
Going forward, we suggest that researchers make the assess-
ment of reliability standard practice when designing and
measuring DNA methylation. This is because, despite evidence
that our individual probe reliabilities correlate highly with those
reliabilities reported previously,17 we do not yet know the full
extent to which demographic (e.g., age), measurement (e.g.,
batch), and source (e.g., tissue) factors may influence measure-
ment reliability. Additionally, specific experimental designs (e.g.,
longitudinal designs and meta-analyses requiring incorporation
of data from different sources, array types and batches, or
cross-sectional single time-point designs) would determine
which type of reliability metric to employ (e.g., within-array
versus between-array); the reliability metrics reported heremight
not be the most suitable. By subsetting our repeated samples
and calculating reliability, we determined that running just 25
replicates will identify 80% of the reliable probes (reliability
>0.75) identified when using 350 replicates (Supplemental Infor-
mation, Section S3.2). Fulfilling this recommendation would
require additional investments during project planning along
with commitment of support from funding agencies. The effort
associated with incorporating reliability assessment into routine
quality control, as we propose, is far outweighed by the benefits
to science from improved replicability. The goal would be, at the
ll
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which conclusions are drawn; this will allow readers to make in-
dependent assessments of the confidence in the probe mea-
surements. Even better would be to filter data, before analysis,
on the basis of reliability metrics. Subsetting data in this way
should help reduce false positives (by reducing the probability
of spurious associations) and possibly false negatives. Although
familywise error-rate corrections would not be greatly affected
(e.g., within the data we present here, Bonferroni correction
would reduce the testing threshold from a = 1.14 3 107 for
440,000 probes to a = 1.77 3 106 for 28,000 probes with
reliability >0.75), false-discovery-rate corrections may be
affected.
Researchers from diverse disciplines have been drawn by
the promise of DNA methylation as a convenient vector by
which the social environment might exert its effects on an or-
ganism’s biology. They are also drawn to the relative simplicity
of Illumina BeadChip data in both content and comprehensive-
ness. Anecdotally, we have encountered two reactions to the
phenomenon of differential reliability. First, some researchers
have expressed little surprise at its existence, coupled with a
belief in the self-correcting power of the field to purge false
negatives and positives over time. Our response to this is
that better use of intellectual and financial resources might be
made in analysis of data that are pre-validated, rather than
cycling through replication attempts using unreliable measures
that are bound to fail. Second, others have expressed shock
and alarm that this phenomenon exists at all; these researchers
are often new to the field and are not intimately familiar with the
nuances of how data are produced or their biological meaning.
Our response here is that DNA methylation data are not univer-
sally unusable—their suitability for analysis is contextual. Deter-
mination of reliability gives researchers confidence in the data
they are using, be they new adopters, end-users, or seasoned
experts.
Open-access availability of data is accelerating with encour-
agement from journal publishers and funding agencies. More
andmore researchers are using these big data; DNAmethylation
data are only one example of such. End-users rely on providers
to verify the integrity of data, but just because data aremassive in
scale does not preclude the need for careful evaluation of their
precision. The reproducibility crisis in science has drawn atten-
tion to two Rs: reproducibility (the extent to which consistent re-
sults are obtainedwhen an experiment is repeated with the exact
same inputs) and replicability (the extent to which consistent re-
sults are obtainedwhen an experiment is repeated with the same
design but with inputs from other sources). Here, we highlight a
potential third ‘‘R,’’ reliability. Reliability is a fundamental aspect
of replicability. If desired inputs do not yield the same value when
the source differs, replication is impossible. In this sense, test-re-
test reliability is a tool that has widespread applicability to the
entire data-science community, especially where big data are
used. The National Academies of Sciences, Engineering, and
Medicine recently published a report45 on the state of reproduc-
ibility and replicability in science, along with suggestions for
improvement: ‘‘.[(r]esearchers should, as applicable to the spe-
cific study, provide an accurate and appropriate characterization
of relevant uncertainties when they report or publish their
research.’’. Unreliable probe measurement is one such uncer-tainty. We hope that our findings will improve the integrity of DNA
methylation studies and serve as a cautionary reminder for those
generating and implementing big data of any type.
EXPERIMENTAL PROCEDURES
Full details are provided in Supplemental Information, Section S3.
Samples
We report data from two samples. The Environmental Risk (E-Risk) Longitudi-
nal Twin Study tracks the development of a 1994–1995 birth cohort of 2,232
British children followed to age 18 years.46 The Dunedin Study tracks the
development of a 1972–1973 birth cohort of 1,037 New Zealand children fol-
lowed to age 45 years.47
DNA Methylation
In E-Risk, DNA was derived from peripheral blood drawn at age 18 years. In
Dunedin, peripheral whole blood was drawn at 38 and 45 years. In E-Risk,
DNA from 350 study members was selected for analysis using both Infinium
MethylationEPIC (EPIC; Illumina, CA, USA) and Illumina Infinium HumanMe-
thylation450 BeadChip (450K BeadChip; Illumina). The remainder of the cohort
(n = 1,308) was assayed using the 450K BeadChip only, as previously
described.48 In Dunedin at age 38, DNA from 819 studymembers was assayed
using the 450K BeadChip, as previously described.48 In Dunedin at age 45,
DNA from 28 study members was assayed twice using the EPIC BeadChip.
E-Risk DNAmethylation assays were run by the Complex Disease Epigenetics
Group at the University of Exeter Medical School (UK) (www.epigenomicslab.
com), and Dunedin assays were run by the Molecular Genomics Shared
Resource at the Duke Molecular Physiology Institute, Duke University (USA).
Gene Expression
RNAwas derived from peripheral blood drawn into PAXGene RNA tubes at age
38 years in Dunedin. Expression data were generated from RNA using the Af-
fymetrix PrimeView Human Gene Chip (Affymetrix, CA, USA) by the Duke Uni-
versity Microarray Core Facility. Data quality control and RMA (robust multi-
chip average) normalization were carried out using the affy Bioconductor
package in the R statistical programming environment. After quality control,
expression data were available for 836 individuals.
Probe Reliabilities
Probe reliabilities are computed using intraclass correlation (ICC) estimates,
calculated for each autosomal probe present on both the EPIC and 450K
BeadChip (N = 438,593). ICCs are an oft-used metric to assess reliability in
test-retest situations,20 and many different models exist depending on the
way in which the test-retest data are generated. Here, we calculated ICCs
based on a mean-rating (k = 2), absolute-agreement, 2-way random-effects
model. To compare whether test-retest model choice had an effect on reli-
ability estimates, we also computed Pearson product-moment correlation co-
efficients. Pearson correlation coefficients and ICC estimates of reliability were
highly similar (r = 1.00, p < 1 3 104; Figure S9).
Statistical Analysis
All analyses were performed in the R statistical programming environment,
often using Bioconductor packages. Unless otherwise noted, correlations
are reported as Pearson correlation coefficients. Summary statistics, such
as probe mean and SD, were based on the 350 samples processed on the
450K array. GSEA was performed using the fgsea Bioconductor package49
with 10,000 permutations. The proportion of variance in DNA methylation ex-
plained by heritable (A), shared environmental (C), and unshared or unique
environmental (E) factors was estimated using structural equation modeling
implemented with functions from the OpenMx R package.50
DATA AND CODE AVAILABILITY
E-Risk 450K DNA methylation data are accessible from the Gene Expression
Omnibus (accession code GEO: GSE105018). Data from the Dunedin Study
are not publicly available due to lack of informed consent and ethical approvalPatterns 1, 100014, May 8, 2020 9
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OPEN ACCESS Articlefor open access, but are available on request by qualified scientists. Requests
require a concept paper describing the purpose of data access, ethical
approval at the applicant’s institution, and provision for secure data access.
We offer secure access on the Duke University, Otago University, and King’s
College London campuses. All data on probe reliability and characteristics
for the 450K-EPIC comparison (Data S1) are available at https://osf.io/
83ucs/. The data underlying analysis of consequences of unreliability on heri-
tability and blood-brain concordance are available from https://www.
epigenomicslab.com/online-data-resources/. Code is available on request
from the corresponding author.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
patter.2020.100014.
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